Zurich Cantonal Bank
STOK icon

Zurich Cantonal Bank’s Stoke Therapeutics STOK Stock Holding History

Zurich Cantonal Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312K Buy
9,582
+453
+5% +$14.9K ﹤0.01% 2075
2025
Q4 		$290K Hold
9,129
– – ﹤0.01% 2072
2025
Q3 		$215K Hold
9,129
– – ﹤0.01% 2159
2025
Q2 		$104K Hold
9,129
– – ﹤0.01% 2373
2025
Q1 		$60.7K Hold
9,129
– – ﹤0.01% 2496
2024
Q4 		$101K Hold
9,129
– – ﹤0.01% 2432
2024
Q3 		$112K Hold
9,129
– – ﹤0.01% 2379
2024
Q2 		$123K Buy
+9,129
New +$123K ﹤0.01% 2293
2022
Q1 		– Sell
-901
Closed -$22K – 2834
2021
Q4 		$22K Sell
901
-94
-9% -$2.24K ﹤0.01% 2851
2021
Q3 		$25K Sell
995
-9
-0.9% -$251 ﹤0.01% 2766
2021
Q2 		$34K Buy
1,004
+52
+5% +$1.84K ﹤0.01% 2528
2021
Q1 		$37K Buy
+952
New +$54.2K ﹤0.01% 2466

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Zurich Cantonal Bank's STOK Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Stoke Therapeutics (STOK) stake by 5% in Q1 2026, buying an estimated $14.9K and bringing the position to 9,582 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Zurich Cantonal Bank first reported a position in STOK in Q1 2021 and has held it in 12 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Zurich Cantonal Bank held 9,582 shares of Stoke Therapeutics worth $312K as of Q1 2026.
  • Zurich Cantonal Bank bought 453 Stoke Therapeutics shares in Q1 2026, an estimated $14.9K.
  • Stoke Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2075 holding.
  • Zurich Cantonal Bank first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 12 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.